ALICIA STARK: Open Payments
NPI 1508095001 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,746 in 205 payments from 22 companies in 2025. Trend: 2023 $2,858 · 2024 $4,163 · 2025 $4,746
Food & beverage: $4,546Education: $200
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 17 | $648 |
| Janssen Biotech, Inc. | 22 | $616 |
| ABBVIE INC. | 31 | $565 |
| UCB, Inc. | 15 | $385 |
| PFIZER INC. | 21 | $333 |
| Regeneron Healthcare Solutions, Inc. | 11 | $280 |
| Lilly USA, LLC | 7 | $247 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $237 |
| Incyte Corporation | 13 | $224 |
| Galderma Laboratories, L.P. | 9 | $216 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, CIBINQO, OPZELURA, Zoryve, RINVOQ.
Industry payments across CO — which companies pay providers there.
